Novel breakthroughs in reprogramming and clinical potential.

Addressing responsible practices, compliance, and global standards.

Investigating therapies for spinal cord injuries, Parkinson’s, and neurodegenerative diseases.

Engineering mini-organs for drug testing and disease modeling.

Advancing treatments for blood cancers, immune disorders, and beyond.

Insights into immunomodulation, inflammation, and regenerative potential.

Bridging laboratory research with real-world clinical applications.

How partnerships, funding, and policy shape the future of the field.